Opioid medication assisted treatment services for beneficiaries addicted to opiates, when determined to be medically necessary and in accordance with an individualized treatment plan. Opioid (Narcotic) Treatment Programs are required to offer and prescribe medication to patients, covered under the DMC-ODS formulary including but not limited to:

• Buprenorphine;
• Naloxone;
• Naltrexone.

Medication Assisted Treatment (MAT) is restricted to the treatment of alcohol dependence and prevention of relapse in opioid dependent patients. The MAT program will include a combination of the following services:

• Physical examination, including any necessary medical tests, by certified medical personnel to determine medical indication of naltrexone;
• Client consent;
• Diagnosis of moderate to severe alcohol use disorder and opioid use disorder;
• Administration of prescription drugs under the supervision of authorized medical personnel; and
• Behavioral treatment and psychosocial support in combination with medication within existing Outpatient or Intensive Outpatient Treatment service regimen.

Common characteristics of opioid dependence include:

• Opioid tolerance (the need to take more drugs to get the same effect, or getting less effect from the same amount of the drug)
• Withdrawal symptoms occur when opioids are not used
• Taking larger amounts of opioids than planned and for longer periods of time
• Persistent desire or unsuccessful attempts to quit spending a lot of time and effort to obtain, use, and recover from opioid use
• Giving up or reducing social or recreational activities; missing work
• Continued opioid use regardless of negative consequences